BayWa's Restructuring Hangs by a Thread as Legal and Financial Crises Converge

German trader BayWa's restructuring depends on a 2026 bank standstill. Asset sales lag, governance crumbles, and legal probes mount, threatening its survival.

The fate of German agricultural trader BayWa rests on a precarious agreement with its banks. Without an extension of the creditor standstill agreement with DZ Bank and HVB until autumn 2026, the company's entire restructuring plan, finalized under Germany's StaRUG insolvency law in May 2025, loses its legal foundation. This single decision will determine whether management retains the operational runway needed to execute a drastic corporate overhaul.

Progress on the core financial restructuring remains painfully slow. The company aims to raise four billion euros through asset sales by 2028 but has secured only 1.3 billion euros so far. A major setback was the collapse of a planned sale of a 51% stake in its renewable energy unit, BayWa r.e., which was initially valued at up to 1.7 billion euros. The deal fell apart after the US cut subsidies for renewable energy in early 2025, destroying the achievable sale price.

In response, management is pinning hopes on the sale of its 74% stake in New Zealand fruit marketer T&G Global. Goldman Sachs was mandated in March 2026 to run the process, with analysts expecting proceeds of around 300 million euros. However, the process is complicated by minority shareholder Joy Wing Mau, which holds nearly 20% of T&G. The target company itself has stressed that no final decision has been made.

Some liquidity is arriving imminently. A payment of 45 million euros from the completed sale of grain trading subsidiary Cefetra, supplemented by roughly 62 million euros from shareholder loans, is due by the end of April. The deconsolidation of Cefetra is expected to reduce the group's bank debt by more than 600 million euros, providing crucial negotiating leverage with lenders.

Simultaneously, BayWa is grappling with a severe governance and legal crisis. The company's supervisory board is crumbling, with Monika Hohlmeier and Michael Höllerer departing on March 31 and Monique Surges set to leave at the end of May. Successors have not been named, meaning only one of the eight shareholder representatives—Joachim Rukwied, president of the farmers' association—remains from the era of former CEO Lutz. In a telling move, the supervisory board has internally lowered the approval threshold for transactions from 200 million to 50 million euros, a direct reaction to the control deficits that contributed to the crisis.

Legal pressures are mounting from multiple directions. Munich I public prosecutors are investigating former CEOs, including Klaus Josef Lutz and Marcus Pöllinger, on suspicion of breach of trust and the intentional misrepresentation of liquidity risks in the 2023 annual report. The presumption of innocence applies to all accused.

Germany's financial regulator, BaFin, has formally reprimanded BayWa for omitting essential details about a billion-euro credit line and specific refinancing risks for a 500-million-euro bond in that same 2023 report. This reprimand has opened the door for shareholder lawsuits. Law firm TILP is preparing damage claims for investors who purchased shares between January 2022 and January 2026, alleging years of capital market deception.

The fallout extends to auditor PwC, which faces proceedings with both BaFin and the audit oversight body Apas. BayWa is terminating PwC's mandate from 2026 and is reviewing its own potential claims for damages. Critically, PwC is not expected to certify the 2025 annual accounts until the fourth quarter of 2026, leaving investors without audited financials for an extended period.

Operationally, the path forward is one of deep contraction. The company plans to focus on four core business areas by the end of 2028, cutting approximately 1,300 jobs and reducing revenue to about ten billion euros. The adjusted EBITDA target for 2027 has been lowered to around 140 million euros, well below the 230 million euros originally aimed for by 2028. The financial forecast for 2026 has been withdrawn entirely.

Investor confidence has evaporated. The share price has lost about a third of its value since November 2025, currently trading at 13.45 euros. This is nearly 37% below its 52-week high of 21.50 euros and roughly 20% below its 200-day moving average. The stock's trajectory for the remainder of the year will be dictated by two pivotal events: the bank agreement and the certified annual financial statements. Both are not expected before the final quarter of 2026, leaving the company and its shareholders in a prolonged state of uncertainty.